Ashkan Shoamanesh
Population Health Research Institute · Population Health Research Institute, Hamilton Health Sciences, McMaster University · Population Health Research Institute, McMaster University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ashkan Shoamanesh as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:59 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07511543 · Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke ThrombectomyPopulation Health Research Institute · not yet recruiting · Ischemic Stroke · principal investigator
- Ph3NCT06587737 · Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral HemorrhagePopulation Health Research Institute · not yet recruiting · Colchicine, ICH - Intracerebral Hemorrhage, Stroke · principal investigator
- N/ANCT05723926 · Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral AnticoagulationJavelin Medical · recruiting · Atrial Fibrillation, Oral Anticoagulation, Stroke · principal investigator
- Ph2NCT05159219 · Colchicine for the Prevention of Vascular Events After an Acute Intracerebral HemorrhagePopulation Health Research Institute · completed · Intracranial Hemorrhages · principal investigator
- Ph4NCT03950076 · EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)Population Health Research Institute · completed · Intracranial Hemorrhages, Atrial Fibrillation · principal investigator
- Ph2NCT02998905 · NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICHPopulation Health Research Institute · completed · Atrial Fibrillation, Intracerebral Hemorrhage · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:59 UTC. The ranking covers the 200 most relevant of 43 PubMed records, and a shared surname and initials can bring in a namesake. All 43 on PubMed
- 752 citationsRCR 32.9
- 412 citationsRCR 36.7
- Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.N Engl J Med · 2024241 citationsRCR 43.3
- 181 citationsRCR 14.4
- Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.Circulation · 2023148 citationsRCR 18.7
- Ultra-Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage.Ann Neurol · 2020139 citationsRCR 7.9
- Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.Lancet Neurol · 2018129 citationsRCR 5.6
- Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.Eur Heart J · 202351 citationsRCR 5.3
- Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.JAMA Neurol · 202047 citationsRCR 2.3
- Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.J Stroke Cerebrovasc Dis · 201844 citationsRCR 2.0